# Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University

> **NCT04353388** · — · COMPLETED · sponsor: **Beckman Coulter, Inc.** · enrollment: 1139 (actual)

## Conditions studied

- Sepsis
- Adult Disease
- Severe Sepsis
- Emergency Department

## Interventions

- **DIAGNOSTIC_TEST:** CBC-DIFF Monocyte Volume Width Distribution (MDW)

## Key facts

- **NCT ID:** NCT04353388
- **Lead sponsor:** Beckman Coulter, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-03
- **Primary completion:** 2020-07-17
- **Final completion:** 2020-07-17
- **Target enrollment:** 1139 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04353388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04353388, "Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04353388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*